The rationale for the study was anecdotal reports of the effects of breast milk used by mothers to treat blocked tear ducts, ...

On the left eye, the patient had conjunctival congestion and hyperemia, a central 2- × 2-mm corneal epithelial defect with deep stromal infiltration, endothelial plaque, moderate anterior chamber ...

ARLINGTON, Mass. - KALA BIO, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on developing treatments for rare and severe eye diseases, announced a change in its executive leadership on Monday ...

OSN, a roundtable discusses the management of epithelial ingrowth after LASIK, neurotrophic keratitis and Demodex blepharitis ...

One eye with membranous keratoconjunctivitis with symblepharon showed resolution of corneal epithelial defect on the seventh day. The ocular surface healed completely with no symblepharon at the ...

Shares of Kala Bio Inc. tumbled over 35% on Wednesday, on track for their worst single-day decline ever, after the company ...

KPI-012 is currently in clinical development for the treatment of persistent corneal epithelial defect (PCED), a rare disease of impaired corneal healing, for which it has received Orphan Drug and ...

Bazemore expressed his commitment to advancing KALA's lead product candidate, KPI-012, which is currently in Phase 2b trials for treating persistent corneal epithelial defect (PCED). Bazemore has ...

AMT has been found to be a good alternative for corneal and conjunctival reconstruction in many clinical situations, including acute burns, persistent epithelial defects of the cornea, and ...